Published in JAMA on January 17, 1996
Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc Natl Acad Sci U S A (1996) 5.34
Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Emerg Infect Dis (2005) 3.90
Emergence of the ehrlichioses as human health problems. Emerg Infect Dis (1996) 3.89
Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin Microbiol Rev (2003) 3.39
Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol (1997) 3.28
Nested PCR assay for detection of granulocytic ehrlichiae. J Clin Microbiol (1998) 3.15
PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species. J Clin Microbiol (1997) 2.59
Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J Clin Microbiol (1998) 2.44
Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect Immun (2003) 2.37
Ehrlichia canis-like agent isolated from a man in Venezuela: antigenic and genetic characterization. J Clin Microbiol (1996) 2.29
Coinfections acquired from ixodes ticks. Clin Microbiol Rev (2006) 2.11
ankA: an Ehrlichia phagocytophila group gene encoding a cytoplasmic protein antigen with ankyrin repeats. Infect Immun (2000) 2.02
Human ehrlichiosis and anaplasmosis. Clin Lab Med (2010) 2.00
Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by Western immunoblot analysis. J Clin Microbiol (1997) 1.98
Prevalence of granulocytic Ehrlichia infection among white-tailed deer in Wisconsin. J Clin Microbiol (1997) 1.78
Major antigenic proteins of the agent of human granulocytic ehrlichiosis are encoded by members of a multigene family. Infect Immun (1998) 1.72
Natural infection of small mammal species in Minnesota with the agent of human granulocytic ehrlichiosis. J Clin Microbiol (1997) 1.70
Increasing incidence of Ehrlichia chaffeensis and Anaplasma phagocytophilum in the United States, 2000-2007. Am J Trop Med Hyg (2011) 1.69
Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect Immun (2000) 1.69
Characterization of monoclonal antibodies to the 44-kilodalton major outer membrane protein of the human granulocytic ehrlichiosis agent. J Clin Microbiol (1998) 1.61
Serologic testing for human granulocytic ehrlichiosis at a national referral center. J Clin Microbiol (1999) 1.58
Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J Clin Invest (1997) 1.56
Molecular cloning and sequencing of three granulocytic Ehrlichia genes encoding high-molecular-weight immunoreactive proteins. Infect Immun (1998) 1.50
Granulocytic Ehrlichiae in Ixodes persulcatus ticks from an area in China where Lyme disease is endemic. J Clin Microbiol (2000) 1.49
Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. J Clin Microbiol (2002) 1.45
Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test. J Clin Microbiol (1999) 1.45
Transcript heterogeneity of the p44 multigene family in a human granulocytic ehrlichiosis agent transmitted by ticks. Infect Immun (2002) 1.43
Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis. Am J Pathol (2001) 1.42
Serological responses to Ehrlichia equi, Ehrlichia chaffeensis, and Borrelia burgdorferi in patients from New York State. J Clin Microbiol (1997) 1.41
Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups. J Clin Microbiol (1997) 1.40
Emerging pathogens: challenges and successes of molecular diagnostics. J Mol Diagn (2008) 1.38
Comparison of the nucleotide sequences of 16S rRNA, 444 Ep-ank, and groESL heat shock operon genes in naturally occurring Ehrlichia equi and human granulocytic ehrlichiosis agent isolates from Northern California. J Clin Microbiol (2000) 1.36
Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis. Expert Rev Anti Infect Ther (2009) 1.33
Animal model of fatal human monocytotropic ehrlichiosis. Am J Pathol (2001) 1.33
Serology of culture-confirmed cases of human granulocytic ehrlichiosis. J Clin Microbiol (2000) 1.32
Human exposure to a granulocytic Ehrlichia and other tick-borne agents in Connecticut. J Clin Microbiol (1998) 1.30
Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect Immun (2000) 1.29
Major surface protein 2 of Anaplasma phagocytophilum facilitates adherence to granulocytes. Infect Immun (2003) 1.29
Mechanisms of variable p44 expression by Anaplasma phagocytophilum. Infect Immun (2003) 1.28
Laboratory findings in cows after experimental infection with Ehrlichia phagocytophila. Clin Diagn Lab Immunol (1997) 1.27
Molecular evidence of coinfection of ticks with Borrelia burgdorferi sensu lato and the human granulocytic ehrlichiosis agent in Switzerland. J Clin Microbiol (1999) 1.27
Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect Immun (2001) 1.26
Expression of interleukin-1beta, tumor necrosis factor alpha, and interleukin-6 in human peripheral blood leukocytes exposed to human granulocytic ehrlichiosis agent or recombinant major surface protein P44. Infect Immun (2000) 1.23
An Ehrlichia strain from a llama (Lama glama) and Llama-associated ticks (Ixodes pacificus). J Clin Microbiol (1997) 1.21
Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1. Infect Immun (1999) 1.20
CXCR2 blockade influences Anaplasma phagocytophilum propagation but not histopathology in the mouse model of human granulocytic anaplasmosis. Clin Diagn Lab Immunol (2004) 1.20
Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates. J Clin Microbiol (1998) 1.17
Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Antimicrob Agents Chemother (1997) 1.17
Ehrlichia phagocytophila genogroup rickettsiae in ixodid ticks from California collected in 1995 and 1996. J Clin Microbiol (1997) 1.17
Infection with Anaplasma phagocytophilum induces multilineage alterations in hematopoietic progenitor cells and peripheral blood cells. Infect Immun (2009) 1.17
Characterization of an immunoreactive protein from the agent of human granulocytic ehrlichiosis. J Clin Microbiol (1997) 1.17
Improved sensitivity of PCR for diagnosis of human granulocytic ehrlichiosis using epank1 genes of Ehrlichia phagocytophila-group ehrlichiae. J Clin Microbiol (2000) 1.16
Restricted changes in major surface protein-2 (msp2) transcription after prolonged in vitro passage of Anaplasma phagocytophilum. BMC Microbiol (2004) 1.14
Serological evidence of human granulocytic ehrlichiosis in Switzerland. Eur J Clin Microbiol Infect Dis (1998) 1.11
Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J Clin Microbiol (2002) 1.11
Serodiagnosis of human granulocytic ehrlichiosis by using novel combinations of immunoreactive recombinant proteins. J Clin Microbiol (2001) 1.10
Serologic evidence of a natural infection of white-tailed deer with the agent of human granulocytic ehrlichiosis in Wisconsin and Maryland. Clin Diagn Lab Immunol (1998) 1.09
The biological basis of severe outcomes in Anaplasma phagocytophilum infection. FEMS Immunol Med Microbiol (2011) 1.09
Human granulocytic anaplasmosis. Infect Dis Clin North Am (2015) 1.08
Clinical and serological follow-up of patients with human granulocytic ehrlichiosis in Slovenia. Clin Diagn Lab Immunol (2001) 1.07
DNA gyrase-mediated natural resistance to fluoroquinolones in Ehrlichia spp. Antimicrob Agents Chemother (2001) 1.07
Analysis of involvement of the RecF pathway in p44 recombination in Anaplasma phagocytophilum and in Escherichia coli by using a plasmid carrying the p44 expression and p44 donor loci. Infect Immun (2006) 1.00
Anaplasma phagocytophilum AptA modulates Erk1/2 signalling. Cell Microbiol (2010) 0.98
Outcomes of treated human granulocytic ehrlichiosis cases. Emerg Infect Dis (2002) 0.97
A human case of monocytic ehrlichiosis with adult respiratory distress syndrome in northern California. West J Med (1996) 0.94
Isolation of the etiologic agent of human granulocytic ehrlichiosis from the white-footed mouse (Peromyscus leucopus). J Clin Microbiol (2001) 0.93
Anaplasma phagocytophilum in central and western Wisconsin: a molecular survey. Parasitol Res (2006) 0.93
Survival of the human granulocytic ehrlichiosis agent under refrigeration conditions. J Clin Microbiol (2000) 0.92
Differential innate immune cell activation and proinflammatory response in Anaplasma phagocytophilum infection. Infect Immun (2007) 0.92
Cytokine gene expression by peripheral blood leukocytes in horses experimentally infected with Anaplasma phagocytophila. Clin Diagn Lab Immunol (2002) 0.92
Comparison of two recombinant major outer membrane proteins of the human granulocytic ehrlichiosis agent for use in an enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (2000) 0.90
Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States. Antimicrob Agents Chemother (2003) 0.90
Cytoplasmic, nuclear, and platelet autoantibodies in human granulocytic ehrlichiosis patients. J Clin Microbiol (1998) 0.90
In vivo and in vitro studies on Anaplasma phagocytophilum infection of the myeloid cells of a patient with chronic myelogenous leukaemia and human granulocytic ehrlichiosis. J Clin Pathol (2004) 0.89
Chronic Lyme Disease and Co-infections: Differential Diagnosis. Open Neurol J (2012) 0.88
Human granulocytic anaplasmosis in the United States from 2008 to 2012: a summary of national surveillance data. Am J Trop Med Hyg (2015) 0.87
Molecular typing of the etiologic agent of human granulocytic ehrlichiosis. J Clin Microbiol (2001) 0.86
Monocytic differentiation inhibits infection and granulocytic differentiation potentiates infection by the agent of human granulocytic ehrlichiosis. Infect Immun (1998) 0.85
Diplorickettsia massiliensis as a human pathogen. Eur J Clin Microbiol Infect Dis (2011) 0.85
Downregulation of CXCL12 signaling and altered hematopoietic stem and progenitor cell trafficking in a murine model of acute Anaplasma phagocytophilum infection. Innate Immun (2011) 0.85
Detection of Anaplasma phagocytophilum DNA in Ixodes ticks (Acari: Ixodidae) from Madeira Island and Setubal District, mainland Portugal. Emerg Infect Dis (2004) 0.85
Evolution of antigen variation in the tick-borne pathogen Anaplasma phagocytophilum. Mol Biol Evol (2011) 0.84
First reported case of Ehrlichia ewingii involving human bone marrow. J Clin Microbiol (2014) 0.83
Prevalence of human-active and variant 1 strains of the tick-borne pathogen Anaplasma phagocytophilum in hosts and forests of eastern North America. Am J Trop Med Hyg (2014) 0.83
Experimental infection of white-tailed deer with Anaplasma phagocytophilum, etiologic agent of human granulocytic anaplasmosis. J Clin Microbiol (2005) 0.83
Severe human granulocytic anaplasmosis transmitted by blood transfusion. Emerg Infect Dis (2012) 0.82
Serologic evidence of Anaplasma phagocytophilum infections in patients with a history of tick bite in central Slovakia. Wien Klin Wochenschr (2008) 0.81
Anaplasma phagocytophilum and Ehrlichia muris induce cytopenias and global defects in hematopoiesis. Clin Microbiol Infect (2009) 0.80
Expansion of the Midwestern focus for human granulocytic anaplasmosis into the region surrounding La Crosse, Wisconsin. J Clin Microbiol (2011) 0.80
Comparison of a real-time PCR method with serology and blood smear analysis for diagnosis of human anaplasmosis: importance of infection time course for optimal test utilization. J Clin Microbiol (2013) 0.80
Isolation and characterization of two European strains of Ehrlichia phagocytophila of equine origin. Clin Diagn Lab Immunol (2002) 0.79
Expression and immunogenicity of recombinant immunoreactive surface protein 2 of Anaplasma phagocytophilum. Clin Vaccine Immunol (2012) 0.79
Pathogenic Landscape of Transboundary Zoonotic Diseases in the Mexico-US Border Along the Rio Grande. Front Public Health (2014) 0.79
Human babesiosis and ehrlichioses--emerging tick-borne diseases. West J Med (1996) 0.78
Clinical manifestations of tick-borne infections in children. Clin Diagn Lab Immunol (2000) 0.78
Natural Anaplasma phagocytophilum infection in ticks from a forest area of Selenge province, Mongolia. Western Pac Surveill Response J (2014) 0.78
Diagnosis of granulocytic ehrlichiosis in humans by immunofluorescence assay. Clin Diagn Lab Immunol (2001) 0.78
Reduced number of interleukin-12 secreting cells in patients with Lyme borreliosis previously exposed to Anaplasma phagocytophilum. Clin Exp Immunol (2006) 0.76
Epidemiology of ehrlichiosis and anaplasmosis among American Indians in the United States, 2000-2007. Am J Trop Med Hyg (2012) 0.75
Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol (1994) 9.97
A critical appraisal of "chronic Lyme disease". N Engl J Med (2007) 7.84
Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA (1994) 6.55
Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med (1996) 5.35
Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis (1995) 5.26
Identification of a novel rickettsial infection in a patient diagnosed with murine typhus. J Clin Microbiol (1994) 4.06
Emergence of the ehrlichioses as human health problems. Emerg Infect Dis (1996) 3.89
Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med (1996) 3.41
Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol (1997) 3.28
Hemocytic rickettsia-like organisms in ticks: serologic reactivity with antisera to Ehrlichiae and detection of DNA of agent of human granulocytic ehrlichiosis by PCR. J Clin Microbiol (1995) 2.38
Positive Lyme disease serology in patients with clinical and laboratory evidence of human granulocytic ehrlichiosis. Am J Clin Pathol (1997) 2.35
Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J Clin Microbiol (1995) 2.32
Transmission and passage in horses of the agent of human granulocytic ehrlichiosis. J Infect Dis (1995) 2.31
Antigenic diversity of granulocytic Ehrlichia isolates from humans in Wisconsin and New York and a horse in California. J Infect Dis (1997) 2.31
Human granulocytic ehrlichiosis in Europe. Lancet (1995) 2.25
Geographic, clinical, serologic, and molecular evidence of granulocytic ehrlichiosis, a likely zoonotic disease, in Minnesota and Wisconsin dogs. J Clin Microbiol (1996) 2.14
Identification of the antigenic constituents of Ehrlichia chaffeensis. Am J Trop Med Hyg (1994) 2.13
PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals. J Clin Microbiol (1998) 2.12
ankA: an Ehrlichia phagocytophila group gene encoding a cytoplasmic protein antigen with ankyrin repeats. Infect Immun (2000) 2.02
Human granulocytic ehrlichiosis in Connecticut: report of a fatal case. Clin Infect Dis (1995) 1.97
Exposure to deer blood may be a cause of human granulocytic ehrlichiosis. Clin Infect Dis (1996) 1.94
Ixodes pacificus (Acari: Ixodidae) as a vector of Ehrlichia equi (Rickettsiales: Ehrlichieae). J Med Entomol (1996) 1.89
Serological evidence of human granulocytic ehrlichiosis in Norway. Eur J Clin Microbiol Infect Dis (1996) 1.84
Emerging bacterial zoonotic and vector-borne diseases. Ecological and epidemiological factors. JAMA (1996) 1.82
Isolation of the equine granulocytic ehrlichiosis agent, Ehrlichia equi, in tick cell culture. J Clin Microbiol (1996) 1.79
Antigenic characterization of ehrlichiae: protein immunoblotting of Ehrlichia canis, Ehrlichia sennetsu, and Ehrlichia risticii. J Clin Microbiol (1992) 1.74
Human granulocytic ehrlichiosis. Clin Infect Dis (2000) 1.72
Natural infection of small mammal species in Minnesota with the agent of human granulocytic ehrlichiosis. J Clin Microbiol (1997) 1.70
Protection against Ehrlichia equi is conferred by prior infection with the human granulocytotropic Ehrlichia (HGE agent). J Clin Microbiol (1995) 1.70
Identification of Ehrlichia in human tissue. N Engl J Med (1991) 1.69
Equine granulocytic ehrlichiosis in Connecticut caused by an agent resembling the human granulocytotropic ehrlichia. J Clin Microbiol (1996) 1.64
Reinfection with the agent of human granulocytic ehrlichiosis. Ann Intern Med (1998) 1.60
Human monocytic and granulocytic ehrlichioses. Discovery and diagnosis of emerging tick-borne infections and the critical role of the pathologist. Arch Pathol Lab Med (1997) 1.58
Comparative pathology, and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections. Am J Trop Med Hyg (2000) 1.55
Isolation and characterization of a new strain of Ehrlichia chaffeensis from a patient with nearly fatal monocytic ehrlichiosis. J Clin Microbiol (1995) 1.54
Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin. Clin Infect Dis (1998) 1.54
Ehrlichia equi infection of horses from Minnesota and Wisconsin: detection of seroconversion and acute disease investigation. J Vet Intern Med (2000) 1.54
Granulocytic Ehrlichiae in Ixodes persulcatus ticks from an area in China where Lyme disease is endemic. J Clin Microbiol (2000) 1.49
The impact of vitamin A supplementation on morbidity: a randomized community intervention trial. Am J Public Health (1991) 1.45
Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test. J Clin Microbiol (1999) 1.45
Clinical, laboratory, and epidemiologic features of murine typhus in 97 Texas children. Arch Pediatr Adolesc Med (2001) 1.45
Identification of Ehrlichia chaffeensis by nested PCR in ticks from Southern China. J Clin Microbiol (2000) 1.44
Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model. J Infect Dis (2000) 1.43
Effect of investments in water supply and sanitation on health status: a threshold-saturation theory. Bull World Health Organ (1981) 1.43
Antibodies to multiple tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in white-footed mice. J Wildl Dis (1997) 1.43
Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis. Am J Pathol (2001) 1.42
False-positive Lyme disease serology in human granulocytic ehrlichiosis. Lancet (1996) 1.42
Serological responses to Ehrlichia equi, Ehrlichia chaffeensis, and Borrelia burgdorferi in patients from New York State. J Clin Microbiol (1997) 1.41
Comparison of the nucleotide sequences of 16S rRNA, 444 Ep-ank, and groESL heat shock operon genes in naturally occurring Ehrlichia equi and human granulocytic ehrlichiosis agent isolates from Northern California. J Clin Microbiol (2000) 1.36
Brief report: fatal seronegative ehrlichiosis in a patient with HIV infection. N Engl J Med (1993) 1.32
Serology of culture-confirmed cases of human granulocytic ehrlichiosis. J Clin Microbiol (2000) 1.32
Detection of Ehrlichia chaffeensis in human tissue by using a species-specific monoclonal antibody. J Clin Microbiol (1993) 1.28
Ultrastructural differentiation of the genogroups in the genus Ehrlichia. J Med Microbiol (1998) 1.28
The incidence of ehrlichial and rickettsial infection in patients with unexplained fever and recent history of tick bite in central North Carolina. J Infect Dis (1999) 1.27
High resolution computed tomography of inflation-fixed lungs. Pathologic-radiologic correlation of centrilobular emphysema. Am Rev Respir Dis (1987) 1.23
An Ehrlichia strain from a llama (Lama glama) and Llama-associated ticks (Ixodes pacificus). J Clin Microbiol (1997) 1.21
Granulocytic ehrlichiosis in dogs from North Carolina and Virginia. J Vet Intern Med (1998) 1.21
PCR detection of adenovirus in a bone marrow transplant recipient: hemorrhagic cystitis as a presenting manifestation of disseminated disease. J Clin Microbiol (1999) 1.20
Human granulocytic ehrlichiosis in Northern California: two case descriptions with genetic analysis of the Ehrlichiae. Clin Infect Dis (1999) 1.18
Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system. J Infect Dis (1999) 1.18
Improved sensitivity of PCR for diagnosis of human granulocytic ehrlichiosis using epank1 genes of Ehrlichia phagocytophila-group ehrlichiae. J Clin Microbiol (2000) 1.16
Quantitative evaluation of ehrlichial burden in horses after experimental transmission of human granulocytic Ehrlichia agent by intravenous inoculation with infected leukocytes and by infected ticks. J Clin Microbiol (1999) 1.14
Serological evidence of human granulocytic ehrlichiosis in Switzerland. Eur J Clin Microbiol Infect Dis (1998) 1.11
Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis. Clin Infect Dis (2001) 1.11
Serodiagnosis of Rocky Mountain spotted fever: comparison of IgM and IgG enzyme-linked immunosorbent assays and indirect fluorescent antibody test. J Infect Dis (1983) 1.10
Serologic evidence of a natural infection of white-tailed deer with the agent of human granulocytic ehrlichiosis in Wisconsin and Maryland. Clin Diagn Lab Immunol (1998) 1.09
Identification of Ehrlichia chaffeensis morulae in cerebrospinal fluid mononuclear cells. J Clin Microbiol (1992) 1.08
Rocky Mountain spotted fever complicated by gangrene: report of six cases and review. Clin Infect Dis (1993) 1.07
Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. Am J Gastroenterol (1998) 1.07
Intestinal helminths and xerophthalmia in Nepal. A case-control study. J Trop Pediatr (1995) 1.07
Reactivity of human sera to different strains of granulocytic ehrlichiae in immunodiagnostic assays. J Infect Dis (1998) 1.06
Fatal pancarditis associated with human granulocytic Ehrlichiosis in a 44-year-old man. Clin Infect Dis (1998) 1.05
Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States. Am J Med (1999) 1.04
Rapid epidemiologic assessment of cataract blindness. The Aravind Rapid Epidemiologic Assessment Staff. Int J Epidemiol (1989) 1.03
A case of equine granulocytic ehrlichiosis provides molecular evidence for the presence of pathogenic anaplasma phagocytophilum (HGE agent) in Germany. Eur J Clin Microbiol Infect Dis (2003) 1.03
Human monocytic ehrlichiosis: an emerging pathogen in transplantation. Transplantation (2001) 0.98
Cutaneous histopathology of Rocky Mountain spotted fever. J Cutan Pathol (1997) 0.98
Experimental inoculation with human granulocytic Ehrlichia agent derived from high- and low-passage cell culture in horses. J Clin Microbiol (2000) 0.98
Immunohistologic demonstration of Coxiella burnetii in the valves of patients with Q fever endocarditis. Am J Med (1994) 0.97
High prevalence of granulocytic Ehrlichiae and Borrelia burgdorferi sensu lato in Ixodes ricinus ticks from Bulgaria. J Clin Microbiol (2001) 0.96
Human granulocytic ehrlichiosis in Bulgaria. Am J Trop Med Hyg (1999) 0.95
Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted fever. J Infect Dis (1983) 0.95
Retrospective serosurvey for human granulocytic ehrlichiosis agent in urban white-footed mice from Maryland. J Wildl Dis (1998) 0.95
A simian model of human granulocytic ehrlichiosis. Am J Trop Med Hyg (1999) 0.94
Ehrlichiosis mimicking thrombotic thrombocytopenic purpura. Case report and pathological correlation. Hum Pathol (1995) 0.91
Human monocytic ehrlichiosis in a child with leukemia. Pediatr Infect Dis J (2000) 0.91
Impact of nutrition education and mega-dose vitamin A supplementation on the health of children in Nepal. Bull World Health Organ (1996) 0.90
Dexamethasone-induced cytokine changes associated with diminished disease severity in horses infected with Anaplasma phagocytophilum. Clin Vaccine Immunol (2011) 0.89
Serological and molecular survey of Anaplasma species infection in dogs with suspected tickborne disease in Portugal. Vet Rec (2009) 0.89
Radiologic-pathologic correlation of the CT halo sign in invasive pulmonary aspergillosis. J Comput Assist Tomogr (1987) 0.88
Electroosmophoretic radioimmunoassay: application to hepatitis-associated antigen. J Nucl Med (1972) 0.88
Severe hepatitis associated with acute Ehrlichia canis infection in a dog. J Vet Intern Med (2010) 0.88
Infection by spotted fever rickettsiae in people, dogs, horses and ticks in Londrina, Parana State, Brazil. Zoonoses Public Health (2011) 0.88